Dr. Elisabeth I Heath, MD
Claim this profileKarmanos Cancer Institute
Area of expertise
Prostate Cancer
Elisabeth I Heath, MD has run 12 trials for Prostate Cancer. Some of their research focus areas include:
Solid Tumors
Elisabeth I Heath, MD has run 3 trials for Solid Tumors. Some of their research focus areas include:
Affiliated Hospitals
Karmanos Cancer Institute
Wayne State University/Karmanos Cancer Institute
Clinical Trials Elisabeth I Heath, MD is currently running
Standard Therapy + Surgery/Radiation
for Prostate Cancer
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Recruiting
2 awards
Phase 3
30 criteria
SGN1
for Solid Tumors
Objectives:To assess the safety and tolerability followed by a dose expansion study to characterize safety, and preliminary efficacy of SGN1 in participants with refractory solid tumors. Study Rationale:The mechanism of action for SGN1 is based on the fact that most tumors are methionine dependent. SGN1 is designed to be used as a tumor therapeutic bacterium that can preferentially replicate and accumulate in tumors and starve them of essential amino acids by delivering the oncolytic enzyme L-Methioninase. Patient Population:The treatment populations shall be patients presenting with histologically confirmed advanced and/or metastatic solid tumors that are refractory to standard therapy and for which no other conventional therapy exists.
Recruiting
1 award
Phase 1 & 2
More about Elisabeth I Heath, MD
Clinical Trial Related
7 years of experience running clinical trials · Led 18 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Elisabeth I Heath, MD has experience with
- Prednisone
- Nivolumab
- Ipilimumab
- Sitravatinib
- SGN1
- The DISCO App
Breakdown of trials Elisabeth I Heath, MD has run
Prostate Cancer
Low Testosterone
Metastases
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Elisabeth I Heath, MD specialize in?
Elisabeth I Heath, MD focuses on Prostate Cancer and Solid Tumors. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are CDK12 positive.
Is Elisabeth I Heath, MD currently recruiting for clinical trials?
Yes, Elisabeth I Heath, MD is currently recruiting for 4 clinical trials in Detroit Michigan. If you're interested in participating, you should apply.
Are there any treatments that Elisabeth I Heath, MD has studied deeply?
Yes, Elisabeth I Heath, MD has studied treatments such as Prednisone, Nivolumab, Ipilimumab.
What is the best way to schedule an appointment with Elisabeth I Heath, MD?
Apply for one of the trials that Elisabeth I Heath, MD is conducting.
What is the office address of Elisabeth I Heath, MD?
The office of Elisabeth I Heath, MD is located at: Karmanos Cancer Institute, Detroit, Michigan 48201 United States. This is the address for their practice at the Karmanos Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.